Implus Footcare, LLC
USPTO PatentsView assignee record - 62 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A63B (Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment).
The verdict
According to USPTO PatentsView, Implus ranks #5,521 of 49,997 tracked US assignees by granted-patent volume, with 62 patents across 6 technology areas.
- #5,521
- of 49,997 US assignees by volume
- 42nd percentile
- by Innovation Score (32.7/100)
- 12.2
- avg claims per patent
- -86%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R5521 · US Corporation #5,521 · 62 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 62 grants
- UPPER-Q #5,521/49,997
- PHOTO-FINISH Hydril USA Distribut…
- CPC-NARROW A63B · 6 areas
- INNOV-THIN 32.7/100
- CLAIMS-RICH 12.2 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -86% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Hydril USA Distribution LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Implus’s 32.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Implus
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Atom Medical · near 33
Atom Medical · near
33 score
- Autumnpaper · near 33
Autumnpaper · near
33 score
- Corsair Pharma · near 33
Corsair Pharma · near
33 score
- Implus Footcare · this assignee 33
Implus Footcare · this assignee
33 score
- Pharnext · near 33
Pharnext · near
33 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Implus's Innovation Score is 32.7/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Implus?
Each dot is one of Implus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Implus’s own 12.2 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Implus's grants concentrate
Implus Footcare, LLC is a focused PatentsView assignee: 6 CPC subclasses with 29% of grants classified under A63B (Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment). Peak complete grant year is 2018 (16 grants) versus a trough of 1 in 2020. By volume, Implus sits between Hydril USA Distribution LLC and Kayaba Industry Co., Ltd..
Implus's three-year grant acceleration
Implus Footcare, LLC shows 4 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Implus's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Hydril USA Distri…
Hydril USA Distribution LLC
62 patents
- IHC Holland IE B V
IHC Holland IE B.V.
62 patents
- Invacare
Invacare Corporation
62 patents
- Imagine Communica…
Imagine Communications Corp.
62 patents
- Infinity Pharmace…
Infinity Pharmaceuticals, Inc.
62 patents
- Innova
Innova Electronics Corporation
62 patents
- International Aid…
International Aids Vaccine Initiative, Inc.
62 patents
- Kayaba Industry
Kayaba Industry Co., Ltd.
62 patents
- Implus Footcare ◀
Implus Footcare, LLC
62 patents
What this shows Implus holds 62 patents at rank #5,520, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Implus
By rank, the assignees closest to #5,520 in granted patent volume.
- Hydril USA Distribution LLC #5,516 · 62 patents
- IHC Holland IE B.V. #5,517 · 62 patents
- Invacare Corporation #5,518 · 62 patents
- Imagine Communications Corp. #5,519 · 62 patents
- Infinity Pharmaceuticals, Inc. #5,521 · 62 patents
- Innova Electronics Corporation #5,522 · 62 patents
- International Aids Vaccine Initiative, Inc. #5,523 · 62 patents
- Kayaba Industry Co., Ltd. #5,524 · 62 patents
Leaders in A63B (Apparatus FOR Physical Training)
Other assignees with the most granted patents in Implus's primary technology class.
- Acushnet Company 1,084 in class
- Nike, Inc. 843 in class
- Karsten Manufacturing Corporation 819 in class
- Taylor Made Golf Company, Inc. 512 in class
- Sumitomo Rubber Industries, Ltd. 436 in class
- Callaway Golf Company 398 in class
- Dunlop Sports Co., Ltd. 301 in class
- Parsons Xtreme Golf, LLC 264 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Implus, neither rank-band nor same-CPC leaders (those blocks stay above). In A63B (Apparatus FOR Physical Training), Implus ranks #63 of 1,021 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (33 here).
Similar claim depth
Nearest assignees by average claims per patent (12.2 here).
Implus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
33 42nd percentile higher than 42% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 8.1% |
| 2016 | 8 | 12.9% |
| 2017 | 14 | 22.6% |
| 2018 | 16 | 25.8% |
| 2019 | 8 | 12.9% |
| 2020 | 1 | 1.6% |
| 2021 | 2 | 3.2% |
| 2023 | 2 | 3.2% |
| 2024 | 2 | 3.2% |
| 2025partial year | 4 | 6.5% |
Which technologies does Implus Footcare, LLC patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Implus Footcare, LLC's patent record in context - here's where to go next.
- Implus Footcare, LLC's lead technology class is A63B (Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment), 29% of its portfolio - see every assignee active in that class. Explore A63B
- Ranked #5,521 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Implus Footcare, LLC against Hydril USA Distribution LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 32.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.